# Quercus Ilex and Quercus Robur Allergen Extracts Standardisation

> **NCT05532566** · NA · RECRUITING · sponsor: **Inmunotek S.L.** · enrollment: 30 (estimated)

## Conditions studied

- Allergic Reaction
- Allergic Skin Reaction
- Allergy Pollen

## Interventions

- **OTHER:** Allergenic extract

## Key facts

- **NCT ID:** NCT05532566
- **Lead sponsor:** Inmunotek S.L.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-24
- **Primary completion:** 2025-11-30
- **Final completion:** 2025-11-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05532566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05532566, "Quercus Ilex and Quercus Robur Allergen Extracts Standardisation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05532566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*